ANNA PHILIPOSE: Open Payments
NPI 1740696467 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 26 payments from 6 companies in 2025. Trend: 2023 $14 · 2024 $52 · 2025 $864
Food & beverage: $864
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $222 |
| E.R. Squibb & Sons, L.L.C. | 7 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $168 |
| Otsuka America Pharmaceutical, Inc. | 3 | $164 |
| Supernus Pharmaceuticals, Inc. | 1 | $95 |
| Corium, LLC | 2 | $10 |
Products named: VRAYLAR, COBENFY, CAPLYTA, REXULTI, Qelbree, Azstarys.
Industry payments across IN — which companies pay providers there.
